2022
DOI: 10.1186/s12951-022-01291-2
|View full text |Cite
|
Sign up to set email alerts
|

Effects of iron oxide nanoparticles as T2-MRI contrast agents on reproductive system in male mice

Abstract: Iron oxide nanoparticles (IONPs)-based contrast agents are widely used for T2-weighted magnetic resonance imaging (MRI) in clinical diagnosis, highlighting the necessity and importance to evaluate their potential systematic toxicities. Although a few previous studies have documented the toxicity concerns of IONPs to major organs, limited data are available on the potential reproductive toxicity caused by IONPs, especially when administrated via intravenous injection to mimic clinical use of MRI contrast agents… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 14 publications
(6 citation statements)
references
References 70 publications
(76 reference statements)
0
6
0
Order By: Relevance
“…Owing to their intrinsic magnetic properties and easy functionalization, they are excellent nanostructures for cancer management, being capable of acting as diagnosis and/or therapeutic agents. In fact, iron oxide nanoparticles have been used in clinical practice as contrast agents for magnetic resonance imaging (MRI) [ 1 ]. On the other hand, the therapeutic interest on MNPs relies on the possibility to guide them with a magnetic field gradient to specific tumor locations, enable the controlled release of drugs using drug-loaded MNPs-based nanosystems, and produce local heat under AC magnetic fields (hyperthermia) [ 2 , 3 ].…”
Section: Introductionmentioning
confidence: 99%
“…Owing to their intrinsic magnetic properties and easy functionalization, they are excellent nanostructures for cancer management, being capable of acting as diagnosis and/or therapeutic agents. In fact, iron oxide nanoparticles have been used in clinical practice as contrast agents for magnetic resonance imaging (MRI) [ 1 ]. On the other hand, the therapeutic interest on MNPs relies on the possibility to guide them with a magnetic field gradient to specific tumor locations, enable the controlled release of drugs using drug-loaded MNPs-based nanosystems, and produce local heat under AC magnetic fields (hyperthermia) [ 2 , 3 ].…”
Section: Introductionmentioning
confidence: 99%
“…Most of them reported that IONs enhanced the efficacy of X-ray energies above Fe K-edge more significantly than conventional broadband high-energy X-rays. Although the FDA has approved several ION formulations, specific unwanted toxicity issues reported in many studies that could be overcome by functionalization and surface modification with various coverage and ligands would be helpful to improve their circulation time, clearance, and evasion by reticuloendothelial system, as well as improving tissue targeting, biocompatibility, and stability [74][75][76][77][78]. It has now been demonstrated that [79] the doxorubicin (DOX)-loaded liposomal iron oxide NPs (IONP) (Lipo-IONP/DOX) might serve as a safe and effective agent for combined chemo/photothermal cancer therapy.…”
Section: Iron-based Nanoparticlesmentioning
confidence: 99%
“…SPIONs-based contrast agents are widely used for T 2 -weighted MRI in medical diagnosis, [39][40][41] where T 2 is referred to as the transverse relaxation of water in tissues caused by the loss of phase coherence or order among the protons in the transverse plane. Therefore, due to their superparamagnetic nature, MTNs aqueous suspension at 100 mg mL À1 was used to investigate transverse relaxation (T 2 ) and examine their suitability in MRI applications.…”
Section: Mri Analysis Of Mtnsmentioning
confidence: 99%